To determine whether an invasive sampling technique presents a serious risk, we
recommend that you base your risk determination on the nature of the harm that
may result from sampling. For example, FDA considers sampling techniques that
require biopsy of a major organ, use of general anesthesia, or placement of a
blood access line into an artery or large vein (subclavian, femoral, or iliac) to
present a significant risk.
